ES12078/ES/NIEHS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	3
2005	1
2006	1
2008	2
2009	4
2010	1
2011	3
2012	1
2025	0

1

Alpha-synuclein and transgenic mouse models.

Fernagut PO, Chesselet MF. Fernagut PO, et al. Neurobiol Dis. 2004 Nov;17(2):123-30. doi: 10.1016/j.nbd.2004.07.001. Neurobiol Dis. 2004. PMID: 15474350 Review.

2

Drosophila models of neurodegenerative disease.

Sang TK, Jackson GR. Sang TK, et al. NeuroRx. 2005 Jul;2(3):438-46. doi: 10.1602/neurorx.2.3.438. NeuroRx. 2005. PMID: 16389307 Free PMC article. Review.

3

Animal models of Parkinson's disease progression.

Meredith GE, Sonsalla PK, Chesselet MF. Meredith GE, et al. Acta Neuropathol. 2008 Apr;115(4):385-98. doi: 10.1007/s00401-008-0350-x. Epub 2008 Feb 14. Acta Neuropathol. 2008. PMID: 18273623 Free PMC article. Review.

4

Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.

Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, Casida JE. Caboni P, et al. Chem Res Toxicol. 2004 Nov;17(11):1540-8. doi: 10.1021/tx049867r. Chem Res Toxicol. 2004. PMID: 15540952

5

Major life events and risk of Parkinson's disease.

Rod NH, Hansen J, Schernhammer E, Ritz B. Rod NH, et al. Mov Disord. 2010 Aug 15;25(11):1639-45. doi: 10.1002/mds.22850. Mov Disord. 2010. PMID: 20602449 Free PMC article.

6

Variable effects of chronic subcutaneous administration of rotenone on striatal histology.

Zhu C, Vourc'h P, Fernagut PO, Fleming SM, Lacan S, Dicarlo CD, Seaman RL, Chesselet MF. Zhu C, et al. J Comp Neurol. 2004 Oct 25;478(4):418-26. doi: 10.1002/cne.20305. J Comp Neurol. 2004. PMID: 15384065

7

Dopamine transporter genetic variants and pesticides in Parkinson's disease.

Ritz BR, Manthripragada AD, Costello S, Lincoln SJ, Farrer MJ, Cockburn M, Bronstein J. Ritz BR, et al. Environ Health Perspect. 2009 Jun;117(6):964-9. doi: 10.1289/ehp.0800277. Epub 2009 Feb 22. Environ Health Perspect. 2009. PMID: 19590691 Free PMC article.

8

Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo.

Meurers BH, Zhu C, Fernagut PO, Richter F, Hsia YC, Fleming SM, Oh M, Elashoff D, Dicarlo CD, Seaman RL, Chesselet MF. Meurers BH, et al. Neurobiol Dis. 2009 Feb;33(2):182-92. doi: 10.1016/j.nbd.2008.10.001. Epub 2008 Oct 26. Neurobiol Dis. 2009. PMID: 19013527 Free PMC article.

9

Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.

Cabeza-Arvelaiz Y, Fleming SM, Richter F, Masliah E, Chesselet MF, Schiestl RH. Cabeza-Arvelaiz Y, et al. Mol Neurodegener. 2011 Dec 13;6:83. doi: 10.1186/1750-1326-6-83. Mol Neurodegener. 2011. PMID: 22165993 Free PMC article.

10

Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.

Hutson CB, Lazo CR, Mortazavi F, Giza CC, Hovda D, Chesselet MF. Hutson CB, et al. J Neurotrauma. 2011 Sep;28(9):1783-801. doi: 10.1089/neu.2010.1723. J Neurotrauma. 2011. PMID: 21644813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year